Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Diabetes Devices Market Analysis

ID: MRFR/HC/10767-HCR
134 Pages
Vikita Thakur
April 2026

Diabetes Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Blood Glucose Monitors, Insulin Delivery Devices, Continuous Glucose Monitoring Systems, Diabetes Management Software), By End Users (Hospitals, Homecare, Diabetes Clinics, Ambulatory Surgical Centers), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Direct Sales), By Applications (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Diabetes Devices Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Analysis

In-depth Analysis of Diabetes Devices Market Industry Landscape

The market of diabetes devices are on the air of changing fast as the more advanced technologies and the increase of the number of diabetes patients around the world impact greatly on diabetic treatment. Diabetes gadgets are diverse and comprise a series of tools and devices that monitor the glucose level, insulin delivery, and the general care of a diabetes patient. An enhanced occurrence of type 2 diabetes and a growing knowledge of the need for efficient diabetes treatments are the main driving forces of the CT device market growth.

A major engine of the wellness devices business development is the proactive movement in the area of the glucose monitoring technologies. This cutting edge new technology will eventually supersede older modes of glucose monitoring which include finger stick tests. They ensure seamless information flows on current glucose levels for patients with diabetes and their medical attendants, doctors and experts who may tailor health programmes or interventions toward specific individuals. The fact that CGMs are convenient, and that they help get more accurate readings of blood sugar, both play an important role in their increasing popularity, and affect the level of care people with diabetes receive.

Insulin discharging gadgets moreover figure out different effect of market dynamics of diabetes devices. The creation of artificial insulin pumps and smart insulin pens have together brought a change to the way process of administration takes place. These gadgets are readily used for precise insulin dosing as well as they facilitate having fewer insulin injections and increase the flexibility in managing insulin. The story of integrating some insulin delivery devices with communication features allows them to share data with healthcare professionals, thus helping in the promotion of better connection and cooperation in the area of diabetes management.

The global diabetes epidemic has made regions where the population is growing rapidly, even fast or very fast mega cities, refer to as “developing markets”. As a result, companies that manufacture devices for diabetes have been driven by the concern to increase their presence in the market and make their devices fit diverse population needs. The two most critical considerations that are to be regarded in these sectors will be affordability and availability which generated the development of the cost effective and user friendly diabetes devices by the companies so that the usage can be much wider for improving the health outcomes.

The birthing of the digital healthcare and the application of smartphone in the management of diabetes play very big role in the changing market dynamics over the year. Mobile apps, which can be coupled with devices used to treat diabetes, make it easy to monitor and store the data about glucose levels, insulin doses, and other significant details. Besides this, most of these applications offer services like trend analysis, medication reminder and have the feature of sharing the data with the healthcare providers, hence, enabling people with diabetes to be in charge of their treatment process.

Author
Author Profile
Vikita Thakur
Senior Research Analyst

She holds an experience of about 5+ years in market research and business consulting projects for sectors such as life sciences, medical devices, and healthcare IT. She possesses a robust background in data analysis, market estimation, competitive intelligence, pipeline analysis market trend identification, and consumer behavior insights. Her expertise lies in technical Sales support, client interaction and project management, designing and implementing market research studies, conducting competitive analysis, and synthesizing complex data into actionable recommendations that drive business growth.

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation of the Diabetes Devices Market by 2035?

<p>The Diabetes Devices Market is projected to reach a valuation of 75.13 USD Billion by 2035.</p>

What was the market valuation of the Diabetes Devices Market in 2024?

<p>In 2024, the market valuation of the Diabetes Devices Market was 32.88 USD Billion.</p>

What is the expected CAGR for the Diabetes Devices Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Diabetes Devices Market during the forecast period 2025 - 2035 is 7.8%.</p>

Which segment of diabetes devices is projected to have the highest growth by 2035?

<p>The Insulin Delivery Devices segment is projected to grow from 10.0 USD Billion in 2024 to 25.0 USD Billion by 2035.</p>

How do the revenues of Type 2 Diabetes devices compare to Type 1 Diabetes devices?

<p>Type 2 Diabetes devices are projected to generate revenues of 20.0 USD Billion in 2024, significantly higher than the 5.0 USD Billion for Type 1 Diabetes devices.</p>

What are the key players in the Diabetes Devices Market?

<p>Key players in the Diabetes Devices Market include Medtronic, Abbott, Roche, Johnson & Johnson, and Dexcom.</p>

Which distribution channel is expected to see the most growth by 2035?

<p>Retail Pharmacies are expected to grow from 10.0 USD Billion in 2024 to 25.0 USD Billion by 2035.</p>

What is the projected revenue for Continuous Glucose Monitoring Systems by 2035?

<p>Continuous Glucose Monitoring Systems are projected to reach revenues of 22.0 USD Billion by 2035.</p>

How does the market for diabetes management software compare to other device types?

<p>Diabetes Management Software is expected to grow from 4.88 USD Billion in 2024 to 10.13 USD Billion by 2035, indicating a steady increase.</p>

What is the anticipated revenue for homecare diabetes devices by 2035?

<p>Homecare diabetes devices are anticipated to generate revenues of 28.0 USD Billion by 2035.</p>

Market Summary

As per Market Research Future analysis, the Diabetes Devices Market was estimated at 32.88 USD Billion in 2024. The Diabetes Devices industry is projected to grow from 35.44 USD Billion in 2025 to 75.13 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.8% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Diabetes Devices Market is experiencing robust growth driven by technological advancements and increasing patient awareness.

  • North America remains the largest market for diabetes devices, reflecting a strong demand for innovative solutions. The Asia-Pacific region is identified as the fastest-growing market, propelled by rising diabetes prevalence and healthcare investments. Blood glucose monitors continue to dominate the market, while continuous glucose monitoring systems are rapidly gaining traction. Key market drivers include the rising prevalence of diabetes and technological innovations in diabetes management.

Market Size & Forecast

2024 Market Size 32.88 (USD Billion)
2035 Market Size 75.13 (USD Billion)
CAGR (2025 - 2035) 7.8%
Largest Regional Market Share in 2024 North America

Major Players

Medtronic (US), Abbott (US), Roche (CH),<a href="https://innovativemedicine.jnj.com/canada/our-focus/cardiovascular-metabolic/diabetes"> Johnson &amp; Johnson </a>(US), Dexcom (US), Boehringer Ingelheim (DE), Insulet (US), Ascensia Diabetes Care (DE), AstraZeneca (GB)

Market Trends

The Diabetes Devices Market is currently experiencing a transformative phase, driven by advancements in technology and an increasing prevalence of diabetes worldwide. Innovations in continuous glucose monitoring systems and insulin delivery devices are reshaping how patients manage their condition. These devices not only enhance patient convenience but also improve health outcomes by providing real-time data and personalized treatment options. Furthermore, the integration of digital health solutions, such as mobile applications and telemedicine, is facilitating better patient engagement and adherence to treatment protocols.

In addition to technological advancements, the diabetes care devices market is influenced by a growing awareness of diabetes management among healthcare professionals and patients alike. Educational initiatives and support programs are becoming more prevalent, encouraging individuals to take proactive steps in managing their health. This shift towards a more informed patient population is likely to drive demand for innovative diabetes devices, as individuals seek tools that empower them to monitor and control their condition effectively. As the Diabetes Devices Market continues to evolve, it appears poised for sustained growth, with a focus on enhancing user experience and improving clinical outcomes.

Technological Advancements

The Diabetes Devices Market is witnessing rapid technological innovations, particularly in continuous glucose monitoring and insulin delivery systems. These advancements are enhancing the accuracy and convenience of diabetes management, allowing patients to monitor their glucose levels in real-time and adjust their insulin intake accordingly.

Integration of Digital Health Solutions

There is a notable trend towards the integration of digital health solutions within the Diabetes Devices Market. Mobile applications and telehealth services are increasingly being utilized to support diabetes management, providing patients with tools for tracking their health data and facilitating communication with healthcare providers.

Growing Patient Awareness

An increase in patient awareness regarding diabetes management is influencing the Diabetes Devices Market. Educational programs and resources are empowering individuals to take charge of their health, leading to a higher demand for innovative devices that support effective monitoring and treatment.

Diabetes Devices Market Market Drivers

Rising Prevalence of Diabetes

The increasing incidence of diabetes worldwide is a primary driver for the Diabetes Devices Market. According to recent statistics, the number of individuals diagnosed with diabetes has surged, with estimates suggesting that over 500 million people are currently living with the condition. This alarming trend necessitates the adoption of advanced diabetes management devices, including continuous glucose monitors and insulin pumps. As the prevalence of diabetes escalates, healthcare systems are compelled to invest in innovative solutions to enhance patient outcomes. Consequently, the demand for diabetes devices is expected to grow, as patients seek effective tools to manage their condition and healthcare providers aim to improve care delivery.

Government Initiatives and Funding

Government initiatives aimed at combating diabetes are influencing the Diabetes Devices Market positively. Various countries have implemented programs to promote diabetes awareness, prevention, and management. These initiatives often include funding for research and development of diabetes devices, as well as subsidies for patients to access necessary technologies. For example, some governments have introduced reimbursement policies for continuous glucose monitoring systems, making them more accessible to patients. Such supportive measures are expected to stimulate market growth, as they encourage innovation and increase the availability of advanced diabetes management tools.

Integration of Telehealth Services

The integration of telehealth services into diabetes management is emerging as a significant driver for the Diabetes Devices Market. Telehealth platforms facilitate remote monitoring and consultations, allowing healthcare providers to engage with patients more effectively. This trend is particularly beneficial for individuals with diabetes, as it enables timely interventions and personalized care plans. The market for telehealth services is expected to expand, with projections indicating a growth rate of approximately 25% annually. As patients increasingly embrace digital health solutions, the demand for compatible diabetes devices that can seamlessly integrate with telehealth platforms is likely to rise, further propelling the market.

Growing Demand for Personalized Medicine

The shift towards personalized medicine is becoming a pivotal driver in the Diabetes Devices Market. Patients are increasingly seeking tailored treatment options that cater to their unique health profiles. This trend is reflected in the rising demand for devices that offer personalized insights and recommendations based on individual glucose patterns. The market for personalized diabetes devices is anticipated to grow significantly, with estimates suggesting a potential increase of over 15% in the next few years. As healthcare providers focus on delivering customized care, the development of devices that integrate personalized data analytics will likely become a key factor in enhancing patient engagement and improving health outcomes.

Technological Innovations in Diabetes Management

Technological advancements play a crucial role in shaping the Diabetes Devices Market. Innovations such as artificial intelligence, machine learning, and advanced sensor technologies are revolutionizing diabetes management. For instance, the development of smart insulin pens and automated insulin delivery systems has transformed how patients manage their blood glucose levels. The market for diabetes devices is projected to witness substantial growth, with estimates indicating a compound annual growth rate of over 10% in the coming years. These innovations not only enhance the accuracy of glucose monitoring but also improve patient adherence to treatment regimens, thereby driving the demand for sophisticated diabetes management solutions.

Market Segment Insights

By Device Type: Blood Glucose Monitors (Largest) vs. Continuous Glucose Monitoring Systems (Fastest-Growing)

The Diabetes Devices Market shows a significant distribution of market share among its key segments. Blood Glucose Monitors hold the largest share, driving consumer preference due to their established presence and easy usability. Insulin Delivery Devices are also crucial, representing a substantial portion of the diabetes care devices market, especially with the increasing reliance on insulin therapy. Continuous Glucose Monitoring Systems are gaining traction as a vital innovation, appealing to tech-savvy patients looking for more precise glucose tracking. Meanwhile, Diabetes Management Software supports these devices, enhancing user experience through integrated data management.

Blood Glucose Monitors (Dominant) vs. Continuous Glucose Monitoring Systems (Emerging)

Blood Glucose Monitors continue to dominate the Diabetes Devices Market, primarily due to their accessibility and familiarity among patients. These devices offer users the convenience of manual testing, appealing to those who prefer straightforward management of their diabetes. In contrast, Continuous Glucose Monitoring Systems are emerging as a pivotal element in diabetes management, providing real-time data to users. Their growth can be attributed to technological advancements, increasing awareness among patients, and a rising focus on proactive health management. As users seek more seamless integration of technology into their care routines, CGMs are becoming an essential choice, signifying a shift towards more dynamic and continuous diabetes management solutions.

By End User: Hospitals (Largest) vs. Homecare (Fastest-Growing)

In the Diabetes Devices Market, hospitals represent the largest share among end users, driven by their established infrastructure and resource availability for managing diabetes. This segment is crucial as it supports comprehensive patient care with advanced tools and technologies. Homecare, on the other hand, is experiencing rapid growth, influenced by increasing patient preferences for self-management and remote monitoring solutions.

Hospitals (Dominant) vs. Homecare (Emerging)

Hospitals serve as the dominant end user in the Diabetes Devices Market, benefiting from robust supply chains and specialized healthcare teams. This segment often employs high-end devices for continuous monitoring and advanced treatment options. In contrast, the homecare segment is emerging rapidly, focusing on user-friendly devices that facilitate self-management and enhance patient independence. The shift towards homecare is fueled by technological advancements in devices that offer connectivity, ease of use, and telehealth integration, catering to the lifestyle changes among diabetes patients who prefer to monitor their condition from home.

By Distribution Channel: Retail Pharmacies (Largest) vs. Online Pharmacies (Fastest-Growing)

In the Diabetes Devices Market, retail pharmacies hold the largest share among distribution channels due to their established presence and accessible locations for patients. They offer a wide range of diabetes devices, which ensures that consumers have reliable access to vital products. Online pharmacies are gaining momentum, appealing to a tech-savvy demographic that prioritizes convenience and home delivery, allowing them to capture a significant portion of the market.

Retail Pharmacies (Dominant) vs. Online Pharmacies (Emerging)

Retail pharmacies are a dominant force in the Diabetes Devices Market, providing patients with immediate access to necessary products, supported by knowledgeable staff who can assist with any inquiries. Their brick-and-mortar presence also allows for physical consultations, which is invaluable for new patients learning to manage their diabetes. On the other hand, online pharmacies represent an emerging segment, capturing the interest of consumers who appreciate the convenience of online shopping. The trend towards digital health and the growing adoption of telemedicine services further bolster the case for online pharmacies as a vital alternative, making them significant competitors in the marketplace.

By Application: Type 2 Diabetes (Largest) vs. Type 1 Diabetes (Fastest-Growing)

In the Diabetes Devices Market, the application segment is predominantly driven by Type 2 Diabetes, representing the largest share due to the increasing prevalence among adults. This condition requires ongoing management, which has led to a higher demand for innovative diabetes management devices. Type 1 Diabetes also holds a significant position, but it is Type 2 Diabetes that leads in volume, fueled by an aging population and rising rates of obesity. The growth trends in this segment are notably influenced by advancements in technology that enhance patient care. Type 1 Diabetes is the fastest-growing segment, attributed to increased awareness and improved diagnostic practices. Additionally, the provision of continuous glucose monitoring devices and integrated insulin delivery systems is catalyzing the development of devices tailored for both Type 1 and Type 2 Diabetes patients, influencing their adoption in the diabetes care devices market.

Type 2 Diabetes: Dominant vs. Type 1 Diabetes: Emerging

Type 2 Diabetes remains the dominant application in the diabetes devices market, reflecting the highest prevalence and a robust demand for management solutions. The ease of use and accessibility of devices specifically designed for Type 2 Diabetes patients contribute to their widespread adoption. In contrast, Type 1 Diabetes, while historically viewed as the less prevalent condition, is emerging rapidly within the diabetes care market due to a rise in the diagnosed cases and advancements in wearable technologies. Continuous glucose monitors tailored for Type 1 patients are gaining traction, supported by a growing base of young patients who are tech-savvy and prefer innovative solutions. This dynamic is causing a shift as newer products are developed to meet the unique needs of Type 1 Diabetes, enhancing their market position.

Get more detailed insights about Diabetes Devices Market Research Report - Forecast Till 2035

Regional Insights

North America : Market Leader in Innovation

North America is the largest market for diabetes devices, holding approximately 45% of the global share. The region benefits from advanced healthcare infrastructure, high prevalence of diabetes, and significant investments in research and development. Regulatory support from agencies like the FDA further catalyzes diabetes care market growth, ensuring rapid approval of innovative devices.

The increasing adoption of continuous glucose monitoring systems and insulin delivery devices is driving demand. The United States is the primary contributor to this market, with key players such as Medtronic, Abbott, and Dexcom leading the charge. The competitive landscape is characterized by continuous innovation and strategic partnerships among these companies. The presence of a well-established distribution network and a growing focus on personalized diabetes management solutions are also pivotal in shaping the market dynamics.

Europe : Emerging Market with Growth Potential

Europe is the second-largest market for diabetes devices, accounting for around 30% of the global market share. The region is witnessing a surge in diabetes prevalence, driven by lifestyle changes and an aging population. Regulatory frameworks, such as the EU Medical Device Regulation, are enhancing product safety and efficacy, thereby boosting consumer confidence. The increasing focus on preventive healthcare and digital health solutions is also propelling diabetes care market growth. Leading countries in this region include Germany, France, and the UK, where companies like Roche and Boehringer Ingelheim are prominent. The competitive landscape is marked by a mix of established players and innovative startups, fostering a dynamic environment for product development. Collaborations between healthcare providers and technology firms are further enhancing the availability of advanced diabetes management solutions.

Asia-Pacific : Rapidly Growing Market

Asia-Pacific is an emerging powerhouse in the diabetes devices market, holding approximately 20% of the global share. The region is experiencing a rapid increase in diabetes cases, driven by urbanization, dietary changes, and sedentary lifestyles. Government initiatives aimed at improving healthcare access and affordability are also contributing to diabetes care market growth. The rising demand for affordable and effective diabetes management solutions is a key driver in this region. Countries like China and India are leading the charge, with significant investments in healthcare infrastructure.

Japan diabetes prevalence rate 2023 dictates that the rate of patients is expected to continue to increase rapidly, fueling the demand diabetes devices. The competitive landscape features both multinational corporations and local manufacturers, creating a diverse market environment. Key players such as Johnson & Johnson and Ascensia Diabetes Care are actively expanding their presence, focusing on innovative products tailored to local needs.

Middle East and Africa : Untapped Market Potential

The Middle East and Africa represent a resource-rich frontier for the diabetes devices market, holding about 5% of the global share. The region faces a rising diabetes prevalence, driven by lifestyle changes and urbanization. Government initiatives aimed at improving healthcare access and awareness are crucial for diabetes care market growth. The increasing focus on chronic disease management and the introduction of health insurance schemes are also expected to drive demand for diabetes devices. Leading countries include South Africa and the UAE, where healthcare investments are on the rise. The competitive landscape is characterized by a mix of international and local diabetes medical device companies, with companies like AstraZeneca and Insulet making significant inroads. The region's unique challenges, such as varying healthcare infrastructure, present both opportunities and hurdles for market expansion.

Key Players and Competitive Insights

The Diabetes Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of diabetes globally. Key diabetes medical device companies such as Medtronic (US), Abbott (US), and Dexcom (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Medtronic (US) focuses on innovation through continuous product development, particularly in insulin delivery systems, while Abbott (US) emphasizes its FreeStyle Libre continuous glucose monitoring (CGM) system, which has gained significant traction due to its user-friendly design. Dexcom (US) is also notable for its commitment to digital health solutions, integrating data analytics to improve patient outcomes. Collectively, these strategies foster a competitive environment that prioritizes technological innovation and patient-centric solutions.
In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several diabetes medical device companies vying for market share, yet dominated by a few key companies that wield substantial influence. This competitive structure allows for a diverse range of products and services, catering to varying patient needs and preferences.
In August 2025, Abbott (US) announced a strategic partnership with a leading telehealth provider to enhance remote patient monitoring capabilities. This collaboration is poised to expand Abbott's reach in the digital health space, allowing for more integrated diabetes management solutions. The significance of this move lies in its potential to improve patient engagement and adherence to treatment plans, thereby enhancing overall health outcomes.
In September 2025, Medtronic (US) launched a new version of its insulin pump, featuring advanced algorithms for automated insulin delivery. This innovation is critical as it positions Medtronic to capture a larger share of the market by appealing to tech-savvy patients seeking more efficient diabetes management solutions. The introduction of this product underscores Medtronic's commitment to leveraging technology to improve patient care.
In October 2025, Dexcom (US) unveiled a new software update for its CGM systems, incorporating artificial intelligence to provide personalized insights for users. This development reflects a broader trend towards AI integration in diabetes management, suggesting that Dexcom is keen on enhancing user experience and fostering better health outcomes through data-driven insights. The strategic importance of this update lies in its potential to differentiate Dexcom in a competitive market increasingly focused on personalized healthcare solutions.
As of October 2025, current competitive trends in the Diabetes Devices Market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, enabling companies to leverage complementary strengths and enhance their product offerings. Looking ahead, it appears that competitive differentiation will increasingly pivot from price-based strategies to innovation, technological advancements, and the reliability of supply chains. This shift may redefine how companies engage with patients and healthcare providers, ultimately shaping the future landscape of diabetes management.

Key Companies in the Diabetes Devices Market include

Industry Developments

Recent developments in the Diabetes Devices Market highlight significant advancements and partnerships among top companies. In September 2023, Medtronic announced enhancements in their continuous glucose monitoring systems, aiming to provide users with improved data accuracy and real-time insights. 

Abbott Laboratories has launched new features for their FreeStyle Libre system, further solidifying their leadership in the sector. In October 2023, Dexcom revealed its partnership with Ascensia Diabetes Care to integrate their technologies, enhancing user experience through app connectivity. The diabetes device sales has reached an impressive milestone, driven by rising global diabetes prevalence and the increasing adoption of smart devices, demonstrating a strong growth trajectory in the next few years.

Future Outlook

Diabetes Devices Market Future Outlook

The Diabetes Devices Market is projected to grow at a 7.8% CAGR from 2025 to 2035, driven by technological advancements, increasing diabetes prevalence, and rising healthcare expenditure.

New opportunities lie in:

  • <p>Development of integrated diabetes management platforms Expansion of <a href="https://www.marketresearchfuture.com/reports/telehealth-market-900">telehealth</a> services for remote monitoring Investment in AI-driven predictive analytics for personalized care</p>

By 2035, the market is expected to be robust, driven by innovation and increased demand.

Market Segmentation

Diabetes Devices Market End User Outlook

  • Hospitals
  • Homecare
  • Diabetes Clinics
  • Ambulatory Surgical Centers

Diabetes Devices Market Application Outlook

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

Diabetes Devices Market Device Type Outlook

  • Blood Glucose Monitors
  • Insulin Delivery Devices
  • Continuous Glucose Monitoring Systems
  • Diabetes Management Software

Diabetes Devices Market Distribution Channel Outlook

  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies
  • Direct Sales

Report Scope

MARKET SIZE 2024 32.88(USD Billion)
MARKET SIZE 2025 35.44(USD Billion)
MARKET SIZE 2035 75.13(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.8% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Medtronic (US), Abbott (US), Roche (CH), Johnson & Johnson (US), Dexcom (US), Boehringer Ingelheim (DE), Insulet (US), Ascensia Diabetes Care (DE), AstraZeneca (GB)
Segments Covered Device Type, End Users, Distribution Channel, Applications, Regional
Key Market Opportunities Integration of artificial intelligence in diabetes management devices enhances patient outcomes and operational efficiency.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the Diabetes Devices Market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Diabetes Devices Market by 2035?

<p>The Diabetes Devices Market is projected to reach a valuation of 75.13 USD Billion by 2035.</p>

What was the market valuation of the Diabetes Devices Market in 2024?

<p>In 2024, the market valuation of the Diabetes Devices Market was 32.88 USD Billion.</p>

What is the expected CAGR for the Diabetes Devices Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Diabetes Devices Market during the forecast period 2025 - 2035 is 7.8%.</p>

Which segment of diabetes devices is projected to have the highest growth by 2035?

<p>The Insulin Delivery Devices segment is projected to grow from 10.0 USD Billion in 2024 to 25.0 USD Billion by 2035.</p>

How do the revenues of Type 2 Diabetes devices compare to Type 1 Diabetes devices?

<p>Type 2 Diabetes devices are projected to generate revenues of 20.0 USD Billion in 2024, significantly higher than the 5.0 USD Billion for Type 1 Diabetes devices.</p>

What are the key players in the Diabetes Devices Market?

<p>Key players in the Diabetes Devices Market include Medtronic, Abbott, Roche, Johnson & Johnson, and Dexcom.</p>

Which distribution channel is expected to see the most growth by 2035?

<p>Retail Pharmacies are expected to grow from 10.0 USD Billion in 2024 to 25.0 USD Billion by 2035.</p>

What is the projected revenue for Continuous Glucose Monitoring Systems by 2035?

<p>Continuous Glucose Monitoring Systems are projected to reach revenues of 22.0 USD Billion by 2035.</p>

How does the market for diabetes management software compare to other device types?

<p>Diabetes Management Software is expected to grow from 4.88 USD Billion in 2024 to 10.13 USD Billion by 2035, indicating a steady increase.</p>

What is the anticipated revenue for homecare diabetes devices by 2035?

<p>Homecare diabetes devices are anticipated to generate revenues of 28.0 USD Billion by 2035.</p>

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Device Type (USD Billion)
    2. | | 4.1.1 Blood Glucose Monitors
    3. | | 4.1.2 Insulin Delivery Devices
    4. | | 4.1.3 Continuous Glucose Monitoring Systems
    5. | | 4.1.4 Diabetes Management Software
    6. | 4.2 Healthcare, BY End User (USD Billion)
    7. | | 4.2.1 Hospitals
    8. | | 4.2.2 Homecare
    9. | | 4.2.3 Diabetes Clinics
    10. | | 4.2.4 Ambulatory Surgical Centers
    11. | 4.3 Healthcare, BY Distribution Channel (USD Billion)
    12. | | 4.3.1 Online Pharmacies
    13. | | 4.3.2 Retail Pharmacies
    14. | | 4.3.3 Hospital Pharmacies
    15. | | 4.3.4 Direct Sales
    16. | 4.4 Healthcare, BY Application (USD Billion)
    17. | | 4.4.1 Type 1 Diabetes
    18. | | 4.4.2 Type 2 Diabetes
    19. | | 4.4.3 Gestational Diabetes
    20. | 4.5 Healthcare, BY Region (USD Billion)
    21. | | 4.5.1 North America
    22. | | | 4.5.1.1 US
    23. | | | 4.5.1.2 Canada
    24. | | 4.5.2 Europe
    25. | | | 4.5.2.1 Germany
    26. | | | 4.5.2.2 UK
    27. | | | 4.5.2.3 France
    28. | | | 4.5.2.4 Russia
    29. | | | 4.5.2.5 Italy
    30. | | | 4.5.2.6 Spain
    31. | | | 4.5.2.7 Rest of Europe
    32. | | 4.5.3 APAC
    33. | | | 4.5.3.1 China
    34. | | | 4.5.3.2 India
    35. | | | 4.5.3.3 Japan
    36. | | | 4.5.3.4 South Korea
    37. | | | 4.5.3.5 Malaysia
    38. | | | 4.5.3.6 Thailand
    39. | | | 4.5.3.7 Indonesia
    40. | | | 4.5.3.8 Rest of APAC
    41. | | 4.5.4 South America
    42. | | | 4.5.4.1 Brazil
    43. | | | 4.5.4.2 Mexico
    44. | | | 4.5.4.3 Argentina
    45. | | | 4.5.4.4 Rest of South America
    46. | | 4.5.5 MEA
    47. | | | 4.5.5.1 GCC Countries
    48. | | | 4.5.5.2 South Africa
    49. | | | 4.5.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Medtronic (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Abbott (US)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Roche (CH)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Johnson & Johnson (US)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Dexcom (US)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Boehringer Ingelheim (DE)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Insulet (US)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Ascensia Diabetes Care (DE)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 AstraZeneca (GB)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY DEVICE TYPE
    4. | 6.4 US MARKET ANALYSIS BY END USER
    5. | 6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    6. | 6.6 US MARKET ANALYSIS BY APPLICATION
    7. | 6.7 CANADA MARKET ANALYSIS BY DEVICE TYPE
    8. | 6.8 CANADA MARKET ANALYSIS BY END USER
    9. | 6.9 CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    10. | 6.10 CANADA MARKET ANALYSIS BY APPLICATION
    11. | 6.11 EUROPE MARKET ANALYSIS
    12. | 6.12 GERMANY MARKET ANALYSIS BY DEVICE TYPE
    13. | 6.13 GERMANY MARKET ANALYSIS BY END USER
    14. | 6.14 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    15. | 6.15 GERMANY MARKET ANALYSIS BY APPLICATION
    16. | 6.16 UK MARKET ANALYSIS BY DEVICE TYPE
    17. | 6.17 UK MARKET ANALYSIS BY END USER
    18. | 6.18 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    19. | 6.19 UK MARKET ANALYSIS BY APPLICATION
    20. | 6.20 FRANCE MARKET ANALYSIS BY DEVICE TYPE
    21. | 6.21 FRANCE MARKET ANALYSIS BY END USER
    22. | 6.22 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    23. | 6.23 FRANCE MARKET ANALYSIS BY APPLICATION
    24. | 6.24 RUSSIA MARKET ANALYSIS BY DEVICE TYPE
    25. | 6.25 RUSSIA MARKET ANALYSIS BY END USER
    26. | 6.26 RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    27. | 6.27 RUSSIA MARKET ANALYSIS BY APPLICATION
    28. | 6.28 ITALY MARKET ANALYSIS BY DEVICE TYPE
    29. | 6.29 ITALY MARKET ANALYSIS BY END USER
    30. | 6.30 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    31. | 6.31 ITALY MARKET ANALYSIS BY APPLICATION
    32. | 6.32 SPAIN MARKET ANALYSIS BY DEVICE TYPE
    33. | 6.33 SPAIN MARKET ANALYSIS BY END USER
    34. | 6.34 SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    35. | 6.35 SPAIN MARKET ANALYSIS BY APPLICATION
    36. | 6.36 REST OF EUROPE MARKET ANALYSIS BY DEVICE TYPE
    37. | 6.37 REST OF EUROPE MARKET ANALYSIS BY END USER
    38. | 6.38 REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    39. | 6.39 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    40. | 6.40 APAC MARKET ANALYSIS
    41. | 6.41 CHINA MARKET ANALYSIS BY DEVICE TYPE
    42. | 6.42 CHINA MARKET ANALYSIS BY END USER
    43. | 6.43 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    44. | 6.44 CHINA MARKET ANALYSIS BY APPLICATION
    45. | 6.45 INDIA MARKET ANALYSIS BY DEVICE TYPE
    46. | 6.46 INDIA MARKET ANALYSIS BY END USER
    47. | 6.47 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    48. | 6.48 INDIA MARKET ANALYSIS BY APPLICATION
    49. | 6.49 JAPAN MARKET ANALYSIS BY DEVICE TYPE
    50. | 6.50 JAPAN MARKET ANALYSIS BY END USER
    51. | 6.51 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    52. | 6.52 JAPAN MARKET ANALYSIS BY APPLICATION
    53. | 6.53 SOUTH KOREA MARKET ANALYSIS BY DEVICE TYPE
    54. | 6.54 SOUTH KOREA MARKET ANALYSIS BY END USER
    55. | 6.55 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    56. | 6.56 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    57. | 6.57 MALAYSIA MARKET ANALYSIS BY DEVICE TYPE
    58. | 6.58 MALAYSIA MARKET ANALYSIS BY END USER
    59. | 6.59 MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    60. | 6.60 MALAYSIA MARKET ANALYSIS BY APPLICATION
    61. | 6.61 THAILAND MARKET ANALYSIS BY DEVICE TYPE
    62. | 6.62 THAILAND MARKET ANALYSIS BY END USER
    63. | 6.63 THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    64. | 6.64 THAILAND MARKET ANALYSIS BY APPLICATION
    65. | 6.65 INDONESIA MARKET ANALYSIS BY DEVICE TYPE
    66. | 6.66 INDONESIA MARKET ANALYSIS BY END USER
    67. | 6.67 INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    68. | 6.68 INDONESIA MARKET ANALYSIS BY APPLICATION
    69. | 6.69 REST OF APAC MARKET ANALYSIS BY DEVICE TYPE
    70. | 6.70 REST OF APAC MARKET ANALYSIS BY END USER
    71. | 6.71 REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    72. | 6.72 REST OF APAC MARKET ANALYSIS BY APPLICATION
    73. | 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. | 6.74 BRAZIL MARKET ANALYSIS BY DEVICE TYPE
    75. | 6.75 BRAZIL MARKET ANALYSIS BY END USER
    76. | 6.76 BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    77. | 6.77 BRAZIL MARKET ANALYSIS BY APPLICATION
    78. | 6.78 MEXICO MARKET ANALYSIS BY DEVICE TYPE
    79. | 6.79 MEXICO MARKET ANALYSIS BY END USER
    80. | 6.80 MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    81. | 6.81 MEXICO MARKET ANALYSIS BY APPLICATION
    82. | 6.82 ARGENTINA MARKET ANALYSIS BY DEVICE TYPE
    83. | 6.83 ARGENTINA MARKET ANALYSIS BY END USER
    84. | 6.84 ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    85. | 6.85 ARGENTINA MARKET ANALYSIS BY APPLICATION
    86. | 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEVICE TYPE
    87. | 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    88. | 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    89. | 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    90. | 6.90 MEA MARKET ANALYSIS
    91. | 6.91 GCC COUNTRIES MARKET ANALYSIS BY DEVICE TYPE
    92. | 6.92 GCC COUNTRIES MARKET ANALYSIS BY END USER
    93. | 6.93 GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    94. | 6.94 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    95. | 6.95 SOUTH AFRICA MARKET ANALYSIS BY DEVICE TYPE
    96. | 6.96 SOUTH AFRICA MARKET ANALYSIS BY END USER
    97. | 6.97 SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    98. | 6.98 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    99. | 6.99 REST OF MEA MARKET ANALYSIS BY DEVICE TYPE
    100. | 6.100 REST OF MEA MARKET ANALYSIS BY END USER
    101. | 6.101 REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    102. | 6.102 REST OF MEA MARKET ANALYSIS BY APPLICATION
    103. | 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. | 6.104 RESEARCH PROCESS OF MRFR
    105. | 6.105 DRO ANALYSIS OF HEALTHCARE
    106. | 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. | 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. | 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. | 6.109 HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE)
    110. | 6.110 HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
    111. | 6.111 HEALTHCARE, BY END USER, 2024 (% SHARE)
    112. | 6.112 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    113. | 6.113 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    114. | 6.114 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
    115. | 6.115 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    116. | 6.116 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    117. | 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY END USER, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY APPLICATION, 2025-2035 (USD Billion)
    8. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    9. | | 7.3.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    10. | | 7.3.2 BY END USER, 2025-2035 (USD Billion)
    11. | | 7.3.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    12. | | 7.3.4 BY APPLICATION, 2025-2035 (USD Billion)
    13. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    14. | | 7.4.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    15. | | 7.4.2 BY END USER, 2025-2035 (USD Billion)
    16. | | 7.4.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    17. | | 7.4.4 BY APPLICATION, 2025-2035 (USD Billion)
    18. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    19. | | 7.5.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    20. | | 7.5.2 BY END USER, 2025-2035 (USD Billion)
    21. | | 7.5.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    22. | | 7.5.4 BY APPLICATION, 2025-2035 (USD Billion)
    23. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    24. | | 7.6.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    25. | | 7.6.2 BY END USER, 2025-2035 (USD Billion)
    26. | | 7.6.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    27. | | 7.6.4 BY APPLICATION, 2025-2035 (USD Billion)
    28. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    29. | | 7.7.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    30. | | 7.7.2 BY END USER, 2025-2035 (USD Billion)
    31. | | 7.7.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    32. | | 7.7.4 BY APPLICATION, 2025-2035 (USD Billion)
    33. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.8.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    35. | | 7.8.2 BY END USER, 2025-2035 (USD Billion)
    36. | | 7.8.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    37. | | 7.8.4 BY APPLICATION, 2025-2035 (USD Billion)
    38. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    39. | | 7.9.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    40. | | 7.9.2 BY END USER, 2025-2035 (USD Billion)
    41. | | 7.9.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    42. | | 7.9.4 BY APPLICATION, 2025-2035 (USD Billion)
    43. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    44. | | 7.10.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    45. | | 7.10.2 BY END USER, 2025-2035 (USD Billion)
    46. | | 7.10.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    47. | | 7.10.4 BY APPLICATION, 2025-2035 (USD Billion)
    48. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    49. | | 7.11.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    50. | | 7.11.2 BY END USER, 2025-2035 (USD Billion)
    51. | | 7.11.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    52. | | 7.11.4 BY APPLICATION, 2025-2035 (USD Billion)
    53. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    54. | | 7.12.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    55. | | 7.12.2 BY END USER, 2025-2035 (USD Billion)
    56. | | 7.12.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    57. | | 7.12.4 BY APPLICATION, 2025-2035 (USD Billion)
    58. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    59. | | 7.13.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    60. | | 7.13.2 BY END USER, 2025-2035 (USD Billion)
    61. | | 7.13.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    62. | | 7.13.4 BY APPLICATION, 2025-2035 (USD Billion)
    63. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.14.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    65. | | 7.14.2 BY END USER, 2025-2035 (USD Billion)
    66. | | 7.14.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    67. | | 7.14.4 BY APPLICATION, 2025-2035 (USD Billion)
    68. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    69. | | 7.15.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    70. | | 7.15.2 BY END USER, 2025-2035 (USD Billion)
    71. | | 7.15.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    72. | | 7.15.4 BY APPLICATION, 2025-2035 (USD Billion)
    73. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    74. | | 7.16.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    75. | | 7.16.2 BY END USER, 2025-2035 (USD Billion)
    76. | | 7.16.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    77. | | 7.16.4 BY APPLICATION, 2025-2035 (USD Billion)
    78. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    79. | | 7.17.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    80. | | 7.17.2 BY END USER, 2025-2035 (USD Billion)
    81. | | 7.17.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    82. | | 7.17.4 BY APPLICATION, 2025-2035 (USD Billion)
    83. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    84. | | 7.18.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    85. | | 7.18.2 BY END USER, 2025-2035 (USD Billion)
    86. | | 7.18.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    87. | | 7.18.4 BY APPLICATION, 2025-2035 (USD Billion)
    88. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    89. | | 7.19.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    90. | | 7.19.2 BY END USER, 2025-2035 (USD Billion)
    91. | | 7.19.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    92. | | 7.19.4 BY APPLICATION, 2025-2035 (USD Billion)
    93. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.20.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    95. | | 7.20.2 BY END USER, 2025-2035 (USD Billion)
    96. | | 7.20.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    97. | | 7.20.4 BY APPLICATION, 2025-2035 (USD Billion)
    98. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    99. | | 7.21.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    100. | | 7.21.2 BY END USER, 2025-2035 (USD Billion)
    101. | | 7.21.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    102. | | 7.21.4 BY APPLICATION, 2025-2035 (USD Billion)
    103. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    104. | | 7.22.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    105. | | 7.22.2 BY END USER, 2025-2035 (USD Billion)
    106. | | 7.22.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    107. | | 7.22.4 BY APPLICATION, 2025-2035 (USD Billion)
    108. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    109. | | 7.23.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    110. | | 7.23.2 BY END USER, 2025-2035 (USD Billion)
    111. | | 7.23.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    112. | | 7.23.4 BY APPLICATION, 2025-2035 (USD Billion)
    113. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    114. | | 7.24.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    115. | | 7.24.2 BY END USER, 2025-2035 (USD Billion)
    116. | | 7.24.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    117. | | 7.24.4 BY APPLICATION, 2025-2035 (USD Billion)
    118. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    119. | | 7.25.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    120. | | 7.25.2 BY END USER, 2025-2035 (USD Billion)
    121. | | 7.25.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    122. | | 7.25.4 BY APPLICATION, 2025-2035 (USD Billion)
    123. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.26.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    125. | | 7.26.2 BY END USER, 2025-2035 (USD Billion)
    126. | | 7.26.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    127. | | 7.26.4 BY APPLICATION, 2025-2035 (USD Billion)
    128. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    129. | | 7.27.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    130. | | 7.27.2 BY END USER, 2025-2035 (USD Billion)
    131. | | 7.27.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    132. | | 7.27.4 BY APPLICATION, 2025-2035 (USD Billion)
    133. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    134. | | 7.28.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    135. | | 7.28.2 BY END USER, 2025-2035 (USD Billion)
    136. | | 7.28.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    137. | | 7.28.4 BY APPLICATION, 2025-2035 (USD Billion)
    138. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    139. | | 7.29.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    140. | | 7.29.2 BY END USER, 2025-2035 (USD Billion)
    141. | | 7.29.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    142. | | 7.29.4 BY APPLICATION, 2025-2035 (USD Billion)
    143. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    144. | | 7.30.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
    145. | | 7.30.2 BY END USER, 2025-2035 (USD Billion)
    146. | | 7.30.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    147. | | 7.30.4 BY APPLICATION, 2025-2035 (USD Billion)
    148. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    149. | | 7.31.1
    150. | 7.32 ACQUISITION/PARTNERSHIP
    151. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Device Type (USD Billion, 2025-2035)

  • Blood Glucose Monitors
  • Insulin Delivery Devices
  • Continuous Glucose Monitoring Systems
  • Diabetes Management Software

Healthcare By End User (USD Billion, 2025-2035)

  • Hospitals
  • Homecare
  • Diabetes Clinics
  • Ambulatory Surgical Centers

Healthcare By Distribution Channel (USD Billion, 2025-2035)

  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies
  • Direct Sales

Healthcare By Application (USD Billion, 2025-2035)

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓
%>